Nursing Management: Acute Kidney Injury and Chronic Kidney Disease

Chapter 47


Nursing Management


Acute Kidney Injury and Chronic Kidney Disease


Carol Headley





Reviewed by Kay Helzer, RN, MSN, Former Renal/Pancreas Transplant Coordinator, Banner Good Samaritan Medical Center, Phoenix, Arizona; and Marci Langenkamp, RN, MS, Assistant Professor of Nursing, Edison Community College, Piqua, Ohio.


Kidney failure (also called renal failure) is the partial or complete impairment of kidney function. It results in an inability to excrete metabolic waste products and water, and it contributes to disturbances of all body systems. Kidney disease can be classified as acute or chronic (Table 47-1). Acute kidney injury (AKI) has a rapid onset. Chronic kidney disease (CKD) is linked with the development of cardiovascular (CV) disease.




image eNursing Care Plan 47-1   Patient With Chronic Kidney Disease














































Nursing Diagnosis*Excess fluid volume related to impaired kidney function as evidenced by edema, hypertension, bounding pulse, weight gain, shortness of breath, pulmonary edema
Patient Goal Maintains an acceptable body weight and fluid balance with dietary modifications and/or with peritoneal dialysis or hemodialysis treatments
Outcomes (NOC) Interventions (NIC) and Rationales




Nursing Diagnosis Risk for electrolyte imbalance related to impaired kidney function resulting in hyperkalemia, hypocalcemia, hyperphosphatemia, and altered vitamin D metabolism
Patient Goals 1. Maintains electrolyte levels within normal ranges
2. Does not experience effects of electrolyte imbalances
Outcomes (NOC) Interventions (NIC) and Rationales







Nursing Diagnosis Imbalanced nutrition: less than body requirements related to restricted intake of nutrients (especially protein), nausea, vomiting, anorexia, and stomatitis as evidenced by loss of appetite and weight
Patient Goals
Outcomes (NOC) Interventions (NIC) and Rationales




Nursing Diagnosis Grieving related to loss of kidney function as evidenced by expression of feelings of sadness, anger, inadequacy, hopelessness
Patient Goals
Outcomes (NOC) Interventions (NIC) and Rationales






image


image


ACLS, Advanced cardiovascular life support; BUN, blood urea nitrogen; Cr, creatinine.


*Nursing diagnoses listed in order of priority.







Acute Kidney Injury


Acute kidney injury (AKI), previously known as acute kidney failure, is the term used to encompass the entire range of the syndrome, ranging from a slight deterioration in kidney function to severe impairment. AKI is characterized by a rapid loss of kidney function. This loss is accompanied by a rise in serum creatinine and/or a reduction in urine output. The severity of dysfunction can range from a small increase in serum creatinine or reduction in urine output to the development of azotemia (an accumulation of nitrogenous waste products [urea nitrogen, creatinine] in the blood).


Although AKI is potentially reversible, it has a high mortality rate.1 AKI usually affects people with other life-threatening conditions2 (Table 47-2). Most commonly, AKI follows severe, prolonged hypotension or hypovolemia or exposure to a nephrotoxic agent.



AKI can develop over hours or days with progressive elevations of blood urea nitrogen (BUN), creatinine, and potassium with or without a reduction in urine output. Hospitalized patients develop AKI at a high rate (1 in 5) and have a high mortality rate. When AKI develops in patients in intensive care units (ICUs), the mortality rate can be as high as 70% to 80%.35



Etiology and Pathophysiology


The causes of AKI, which are multiple and complex, are categorized as prerenal, intrarenal (or intrinsic), and postrenal causes (see Table 47-2).



Prerenal.


Prerenal causes of AKI are factors external to the kidneys. These factors reduce systemic circulation, causing a reduction in renal blood flow. The decrease in blood flow leads to decreased glomerular perfusion and filtration of the kidneys. Although kidney tubular and glomerular function is preserved, glomerular filtration is reduced as a result of decreased perfusion.


It is important to distinguish prerenal oliguria from the oliguria of intrarenal AKI. In prerenal oliguria there is no damage to the kidney tissue (parenchyma). The oliguria is caused by a decrease in circulating blood volume (e.g., severe dehydration, heart failure [HF], decreased cardiac output) and is readily reversible with appropriate treatment. With a decrease in circulating blood volume, autoregulatory mechanisms that increase angiotensin II, aldosterone, norepinephrine, and antidiuretic hormone attempt to preserve blood flow to essential organs. Prerenal azotemia results in a reduction in the excretion of sodium (less than 20 mEq/L), increased sodium and water retention, and decreased urine output.


Prerenal conditions can lead to intrarenal disease if renal ischemia is prolonged. Prerenal conditions account for many cases of intrarenal AKI. If decreased perfusion persists for an extended time, the kidneys lose their ability to compensate and damage to kidney parenchyma occurs (intrarenal damage).



Intrarenal.


Intrarenal causes of AKI (see Table 47-2) include conditions that cause direct damage to the kidney tissue, resulting in impaired nephron function. The damage from intrarenal causes usually results from prolonged ischemia, nephrotoxins (e.g., aminoglycoside antibiotics, contrast media), hemoglobin released from hemolyzed red blood cells (RBCs), or myoglobin released from necrotic muscle cells.


Nephrotoxins can cause obstruction of intrarenal structures by crystallizing or by causing damage to the epithelial cells of the tubules. Hemoglobin and myoglobin can block the tubules and cause renal vasoconstriction. Diseases of the kidney such as acute glomerulonephritis and systemic lupus erythematosus may also cause AKI.


Acute tubular necrosis (ATN) is the most common intrarenal cause of AKI and is primarily the result of ischemia, nephrotoxins, or sepsis (Fig. 47-1). Ischemic and nephrotoxic ATN is responsible for 90% of intrarenal AKI cases.6,7 Severe kidney ischemia causes a disruption in the basement membrane and patchy destruction of the tubular epithelium. Nephrotoxic agents cause necrosis of tubular epithelial cells, which slough off and plug the tubules. ATN is potentially reversible if the basement membrane is not destroyed and the tubular epithelium regenerates.



ATN is the most common cause of AKI for hospitalized patients. Risks associated with development of ATN while in the hospital include major surgery, shock, sepsis, blood transfusion reaction, muscle injury from trauma, prolonged hypotension, and nephrotoxic agents (see Table 47-2).




Clinical Manifestations


Prerenal and postrenal AKI that has not caused intrarenal damage usually resolves quickly with treatment of the cause. However, when parenchymal damage occurs due to either prerenal or postrenal causes, or when parenchymal damage occurs directly as with intrarenal causes, AKI has a prolonged course. Clinically, AKI may progress through phases: oliguric, diuretic, and recovery. When a patient does not recover from AKI, then CKD may develop.


The RIFLE classification is used to describe the stages of AKI (Table 47-3). Risk, the first stage of AKI, is followed by Injury, which is the second stage. Then AKI increases in severity to the final or third stage, Failure. The two outcome variables are Loss and End-stage kidney disease. (See eTable 47-2 for a case study showing how RIFLE classification is used.)




Oliguric Phase.


Manifestations of AKI are presented in eTable 47-1 (available on the website for this chapter). The most common manifestations are discussed in this section.



Urinary Changes.

The most common initial manifestation of AKI is oliguria, a reduction in urine output to less than 400 mL/day. Nonoliguria AKI indicates a urine output greater than 400 mL/day. Oliguria usually occurs within 1 to 7 days of the injury to the kidneys. If the cause is ischemia, oliguria often occurs within 24 hours. In contrast, when nephrotoxic drugs are involved, the onset may be delayed for as long as 1 week. The oliguric phase lasts on average about 10 to 14 days but can last months in some cases. The longer the oliguric phase lasts, the poorer the prognosis for complete recovery of kidney function.1


About 50% of patients will not be oliguric, making the initial diagnosis more difficult.5 Changes in urine output generally do not correspond to changes in glomerular filtration rate (GFR). However, changes in urine output are often helpful in differentiating the etiology of AKI. For example, anuria is usually seen with urinary tract obstruction, oliguria is commonly seen with prerenal etiologies, and nonoliguric AKI is seen with acute interstitial nephritis and ATN.8


A urinalysis may show casts, RBCs, and white blood cells (WBCs). The casts are formed from mucoprotein impressions of the necrotic renal tubular epithelial cells, which detach or slough into the tubules. In addition, a urinalysis may show a specific gravity fixed at around 1.010 and urine osmolality at about 300 mOsm/kg (300 mmol/kg). This is the same specific gravity and osmolality of plasma, thus reflecting tubular damage with a loss of concentrating ability by the kidney. Proteinuria may be present if kidney failure is related to glomerular membrane dysfunction.






Potassium Excess.

The kidneys normally excrete 80% to 90% of the body’s potassium. In AKI the serum potassium level increases because the kidney’s normal ability to excrete potassium is impaired. Hyperkalemia is more of a risk if AKI is caused by massive tissue trauma because the damaged cells release additional potassium into the extracellular fluid. Additionally, bleeding and blood transfusions may cause cellular destruction, releasing more potassium into the extracellular fluid. Last, acidosis worsens hyperkalemia as hydrogen ions enter the cells and potassium is driven out of the cells into the extracellular fluid.


Even though patients with hyperkalemia are usually asymptomatic, some patients may complain of weakness with severe hyperkalemia. Acute or rapid development of hyperkalemia may result in clinical signs that are apparent on electrocardiogram (ECG). These changes include peaked T waves, widening of the QRS complex, and ST segment depression. Progressive changes in the ECG that are related to increasing potassium levels are depicted in Fig. 17-14. Because cardiac muscle is intolerant of acute increases in potassium, treatment is essential whenever hyperkalemia develops.9

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 17, 2016 | Posted by in NURSING | Comments Off on Nursing Management: Acute Kidney Injury and Chronic Kidney Disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access